NCT01336231|Terminated
Study Stopped
lack of recruitment
Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer
COG-ANGIO
Loading search results
Sponsor study identifier
observational
82
1 country
6
Study Start
October 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2013
Actual (reported)Study Completion
June 2013
Actual (reported)Longitudinal study nonrandomized, multicenter observational descriptive monitoring patients treated with anti-angiogenic for metastatic kidney cancer
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2008
Date type not reportedThis date has not been verified as actual or estimated.
April 12, 2011
Actual (reported)April 15, 2011
Actual (reported)June 2013
Actual (reported)June 2013
Actual (reported)Impact of fatigue, memory problems and attentional
Assessing the impact of fatigue, memory problems and attentional induced by an anti-angiogenic and study their evolution over time in patients with metastatic kidney cancer.
up to 12 months after treatment
Parameters of quality of life
up to 12 months after treatment
disorders of cognitive functions
up to 12 months after treatment
biological disturbances
up to 9 months after treatment
Impact of anxiety and depression
up to 12 months after treatment
List of symptoms
up to 12 months after treatment
Patients with a metastatic kidney cancer and must beginning a treatment by antiangiogenic
Patients with a metastatic kidney cancer and must beginning a treatment by antiangiogenic
Centre François BACLESSE
Caen, Calvados, 14076, France
Centre Henri Becquerel
Rouen, Seine Maritime, 76000, France
CHU
Rouen, Seine Maritime, 76038, France
CHU
Strasbourg, 67091, France
Institut Gustave Roussy
Villejuif, 94805, France
Hôpital Georges Pompidou
Paris, Île-de-France Region, 75908, France
Florence JOLY-LOBBEDEZ, PD
Centre François Baclesse
82 participants (actual enrollment reported by the registry).
First Submitted
April 12, 2011
First Posted
April 15, 2011
Study Start
October 2008
Date type not reportedThis date has not been verified as actual or estimated.
CARE1 Pragmatic Clinical Trial
Contact the study team to confirm eligibility.
Primary Completion
June 2013
Actual (reported)Study Completion
June 2013
Actual (reported)Last Updated
July 21, 2016
Record last verified: 2016-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: